Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity
Markus Hoffmann, Heike Hofmann-Winkler, Joan C. Smith, et al.
EBioMedicine (2021) Vol. 65, pp. 103255-103255
Open Access | Times Cited: 329

Showing 26-50 of 329 citing articles:

Targeting ACE2 for COVID-19 Therapy: Opportunities and Challenges
Hongpeng Jia, Enid Neptune, Honggang Cui
American Journal of Respiratory Cell and Molecular Biology (2020) Vol. 64, Iss. 4, pp. 416-425
Open Access | Times Cited: 89
Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection
Pablo Fuentes‐Prior
Journal of Biological Chemistry (2020) Vol. 296, pp. 100135-100135
Open Access | Times Cited: 82
A CRISPR/Cas9 genetically engineered organoid biobank reveals essential host factors for coronaviruses
Joep Beumer, Maarten H. Geurts, Mart M. Lamers, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 74
Potential role of interferons in treating COVID-19 patients
Mohadeseh Haji Abdolvahab, Shima Moradi‐Kalbolandi, Mohammad Zarei, et al.
International Immunopharmacology (2020) Vol. 90, pp. 107171-107171
Open Access | Times Cited: 71
MPI8 is Potent against SARS‐CoV‐2 by Inhibiting Dually and Selectively the SARS‐CoV‐2 Main Protease and the Host Cathepsin L**
R. Xinyu, Yugendar R. Alugubelli, Yuying Ma, et al.
ChemMedChem (2021) Vol. 17, Iss. 1
Open Access | Times Cited: 66
Precision‐cut lung slices: A powerful ex vivo model to investigate respiratory infectious diseases
Flávia Viana, Cecilia M. O’Kane, Gunnar N. Schroeder
Molecular Microbiology (2021) Vol. 117, Iss. 3, pp. 578-588
Open Access | Times Cited: 58
Protective Role of a TMPRSS2 Variant on Severe COVID-19 Outcome in Young Males and Elderly Women
Maria Monticelli, Bruno Hay Mele, Elisa Benetti, et al.
Genes (2021) Vol. 12, Iss. 4, pp. 596-596
Open Access | Times Cited: 57
The Transmembrane Protease TMPRSS2 as a Therapeutic Target for COVID-19 Treatment
Lukas Wettstein, Frank Kirchhoff, Jan Münch
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1351-1351
Open Access | Times Cited: 57
SARS-CoV-2 Antiviral Therapy
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Clinical Microbiology Reviews (2021) Vol. 34, Iss. 4
Open Access | Times Cited: 57
Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry
Edward R. Kastenhuber, Marisa Mercadante, Benjamin E. Nilsson-Payant, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 55
Recent review of COVID-19 management: diagnosis, treatment and vaccination
Vivek P. Chavda, Suneetha Vuppu, Toshika Mishra, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 6, pp. 1120-1148
Open Access | Times Cited: 55
Antidepressant and Antipsychotic Drugs Reduce Viral Infection by SARS-CoV-2 and Fluoxetine Shows Antiviral Activity Against the Novel Variants in vitro
Senem Merve Fred, Suvi Kuivanen, Hasan Uğurlu, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 52
SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-β signaling
Scott B. Biering, Francielle Tramontini Gomes de Sousa, Laurentia V. Tjang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 50
A common TMPRSS2 variant has a protective effect against severe COVID-19
Alessia David, Nick Parkinson, Thomas P. Peacock, et al.
Current Research in Translational Medicine (2022) Vol. 70, Iss. 2, pp. 103333-103333
Open Access | Times Cited: 47
Role of Extracellular Trap Release During Bacterial and Viral Infection
Bárbara M. Schultz, Orlando A. Acevedo, Alexis M. Kalergis, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 47
Spike protein mediated membrane fusion during SARS‐CoV‐2 infection
Xinyu Li, Huijun Yuan, Xiaozhen Li, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 45
Altered host protease determinants for SARS-CoV-2 Omicron
Jasper Fuk‐Woo Chan, Xiner Huang, Bingjie Hu, et al.
Science Advances (2023) Vol. 9, Iss. 3
Open Access | Times Cited: 32
SARS-CoV-2 Omicron entry is type II transmembrane serine protease-mediated in human airway and intestinal organoid models
Anna Z. Mykytyn, Tim I. Breugem, Maarten H. Geurts, et al.
Journal of Virology (2023) Vol. 97, Iss. 8
Open Access | Times Cited: 28
Antiviral, anti-inflammatory and antioxidant effects of curcumin and curcuminoids in SH-SY5Y cells infected by SARS-CoV-2
Tiago Nicoliche, Cynthia Silva Bartolomeo, Robertha Mariana Rodrigues Lemes, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 16
Structural basis of TMPRSS2 zymogen activation and recognition by the HKU1 seasonal coronavirus
I. Fernández, Nell Saunders, S. Duquerroy, et al.
Cell (2024) Vol. 187, Iss. 16, pp. 4246-4260.e16
Open Access | Times Cited: 15
SARS-CoV-2 mechanisms of cell tropism in various organs considering host factors
Emad Behboudi, Seyed Nooreddin Faraji, Gholamreza Daryabor, et al.
Heliyon (2024) Vol. 10, Iss. 4, pp. e26577-e26577
Open Access | Times Cited: 9
Transformative Approaches in SARS-CoV-2 Management: Vaccines, Therapeutics and Future Direction
Ankita Saha, Shweta Choudhary, Priyanshu Walia, et al.
Virology (2025) Vol. 604, pp. 110394-110394
Closed Access | Times Cited: 1
Development of ketobenzothiazole-based peptidomimetic TMPRSS13 inhibitors with low nanomolar potency
Alexandre Joushomme, Antoine Désilets, William Champagne, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2025) Vol. 40, Iss. 1
Open Access | Times Cited: 1
Malabaricone C isolated from edible plants as a potential inhibitor of SARS-CoV-2 infection
Mutmainah, Yuta Murai, Ai Fujimoto, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Dual inhibition of TMPRSS2 and Cathepsin B prevents SARS-CoV-2 infection in iPS cells
Rina Hashimoto, Ayaka Sakamoto, Sayaka Deguchi, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 26, pp. 1107-1114
Open Access | Times Cited: 52

Scroll to top